-
Palonosetron, sold
under the
brand name Aloxi, is a
medication used for the
prevention and
treatment of chemotherapy-induced
nausea and
vomiting (CINV)...
- Netupitant/
palonosetron, sold
under the
brand name Akynzeo, is a fixed-dose
combination medication used for the
prevention of
acute and dela**** chemotherapy-induced...
-
United States, the
combinations of netupitant/
palonosetron and the
prodrug fosnetupitant/
palonosetron (both
brand name Akynzeo) are
approved by the Food...
- was
approved by the FDA in 1997, and is also
administered once daily.
Palonosetron is the
newest 5-HT3
antagonist to
become available in the U.S. market...
- vomiting. It is a
prodrug of netupitant. It is used in
combination with
palonosetron hydrochloride and
formulated as the salt
fosnetupitant chloride hydrochloride...
- for US$3.9 billion. This
event brought Dacogen (decitabine),
Aloxi (
palonosetron),
Hexalen (altretamine) for
ovarian cancer, and the
Gliadel Wafer (carmustine)...
- of 2019.
Activase (alteplase), for
heart attacks.
Akynzeo (netupitant/
palonosetron), for
nausea and vomiting,
licensed by
Eisai Co. and
Helsinn Therapeutics...
-
Granisetron A04AA03
Tropisetron A04AA04
Dolasetron A04AA05
Palonosetron A04AA55
Palonosetron,
combinations A04AD01
Scopolamine A04AD02
Cerium oxalate A04AD04...
- also
block 5-HT3
receptors in CTZ and STN. The
newest 5-HT3 inhibitor,
palonosetron (Aloxi), also
prevents dela****
nausea and vomiting,
which can
occur during...
-
Galanolactone Granisetron Hydroxybupropion Lerisetron Memantine Ondansetron Palonosetron Ramosetron Renzapride Ricasetron Tedatioxetine Tetracyclic antidepressants...
